Belgium encourages OTC nasal corticosteroids

8 March 2017 - Deborah Wilkes

Archived

Belgium's Federal Agency for Medicines and Health Products (FAMHP) is encouraging companies to switch their nasal corticosteroids from prescription to non-prescription status.

Click tags below for more information on topics:

FAMHP

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: